This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revision | Last revisionBoth sides next revision | ||
home:diseases:ibs [03.13.2019] – [Further researxh] sallieq | home:diseases:ibs [03.15.2019] – [Further research] sallieq | ||
---|---|---|---|
Line 53: | Line 53: | ||
In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity. | In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity. | ||
+ | |||
+ | Mast cell activation syndromes | ||
+ | |||
+ | Gastrointestinal (GI) symptoms are commonly reported in patients with mast cell disease. | ||
+ | |||
+ | Mast cells are located in close proximity to the vasculature, | ||
+ | |||
+ | Mast cell activation plays an important role in stress-mediated disease pathogenesis. | ||
+ | |||